Artificial Intelligence (AI) can be a great tool in diagnosing and management of atopic dermatitis -- a chronic skin conditi ...

The report by GlobalData, a data and analytics company, showed that the global burden of 12-month diagnosed prevalent cases ...

A study revealed that parents of children with atopic dermatitis experience less than optimal sleep and are more reliant on ...

A brief self-guided online Cognitive Behavioral Therapy (CBT) intervention was noninferior to comprehensive clinician-guided ...

The global prevalence of atopic dermatitis -- a chronic skin condition -- is expected to reach 42.42 million by 2033, ...

With over 1,100 subjects enrolled across 39 clinical study sites, the company is developing and validating the study.

Approval of the topical aryl hydrocarbon receptor agonist was supported by the pivotal ADORING studies. In the ...

Data from lowest dose level cohorts demonstrate a favorable safety and efficacy profileData includes complete results from ...

A new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as ...

Corvus Pharmaceuticals' stock plummeted ~40% after Phase 1 data for soquelitinib in AD showed mixed results. See why I ...

The U.S. Food and Drug Administration has approved Organon's Vtama (tapinarof) 1% cream for an additional indication -- the ...

The FDA has blessed two previously approved medicines—one a cream and the other an injection—to treat atopic dermatitis (AD).